Powder: -20°C for 3 years | In solvent: -80°C for 1 year
K-80003(TX-803) is a potent retinol-like X-receptor-alpha regulator that inhibits TRxrα-dependent Akt activation and tumor cell growth.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 77.00 | |
5 mg | In stock | $ 125.00 | |
10 mg | In stock | $ 183.00 | |
25 mg | In stock | $ 297.00 | |
50 mg | In stock | $ 453.00 | |
100 mg | In stock | $ 667.00 | |
500 mg | In stock | $ 1,420.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 135.00 |
Description | K-80003(TX-803) is a potent retinol-like X-receptor-alpha regulator that inhibits TRxrα-dependent Akt activation and tumor cell growth. |
In vitro | In MCF-7 cells, cotreatment with K-80003 inhibits the TNFα-induced colocalization of tRXRα with p85α in the cytoplasm, leading to tRXRα nuclear localization. Western blotting reveals that the K-80003-stabilized tetrameric form of tRXRα is exclusively present in the nuclear fraction, while the tRXRα monomer is distributed in both nuclear and cytoplasmic fractions [1]. |
In vivo | K-80003, a potent inhibitor of AKT activation by all-trans-retinoic acid, exhibits enhanced efficacy in inhibiting tRXRα-dependent AKT activation and tRXRα tumor growth in animals. K-80003 has high affinity for RXRα but lacks COX inhibitory activity [2]. |
Synonyms | TX-803 |
Molecular Weight | 336.4 |
Formula | C22H21FO2 |
CAS No. | 1292821-90-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 20 mg/mL (59.45 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
K-80003 1292821-90-9 Cytoskeletal Signaling Metabolism PI3K/Akt/mTOR signaling RAR/RXR Akt TX-803 K 80003 TX 803 TX803 K80003 inhibitor inhibit